Bio Pharma Dive
MARCH 18, 2023
The eagerly anticipated results from a Phase 2 study in psoriasis show why the pharma paid $4 billion to buy the drug from startup Nimbus Therapeutics last year.
NPR Health - Shots
MARCH 18, 2023
Five people in Washington state got sick after eating frozen strawberries from the same supplier, federal regulatory investigators said. The FDA is urging people to stop eating certain products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT News
MARCH 18, 2023
Doctors and investors are getting their first glimpse of the data that compelled Takeda Pharmaceutical to make a $6 billion bet on an experimental pill. The drug, which it acquired from Boston biotech Nimbus Therapeutics last month, blocks a key lever in the immune system that Takeda believes has the potential to treat numerous autoimmune and inflammatory diseases.
Medical Xpress
MARCH 18, 2023
University of Utah Health scientists have corrected abnormal heart rhythms in mice by restoring healthy levels of a protein that heart cells need to establish connections with one another. That protein, GJA1-20k, is underproduced in people with a genetic condition called arrhythmogenic cardiomyopathy, one of the leading causes of sudden cardiac arrest in athletes under the age of 35.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Patent Watch
MARCH 18, 2023
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are ten patents protecting… The post New patent expiration for Acorda drug INBRIJA appeared first on DrugPatentWatch - Make Better Decisions.
Medical Xpress
MARCH 18, 2023
In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly's move.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
MARCH 18, 2023
A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they become popular resources for cancer information. They found these resources give accurate information when asked about common cancer myths and misconceptions. In the first study of its kind, Skyler Johnson, MD, physician-scientist at Huntsman Cancer Institute and assistant professor in the department of radiation oncology at the University of Utah (the U), evaluate
Cloudbyz
MARCH 18, 2023
Contract Research Organizations (CROs) play a crucial role in helping biotech companies conduct clinical trials and bring drugs to market. Here are some ways that CROs can improve their operations to better serve biotech companies: Invest in technology: CROs can improve their operations by investing in technology that can streamline and automate their processes.
Medical Xpress
MARCH 18, 2023
Wyoming Gov. Mark Gordon signed a bill Friday night prohibiting abortion pills in the state and also allowed a separate measure restricting abortion to become law without his signature.
NPR Health - Shots
MARCH 18, 2023
More drug companies lowered list prices for insulin this week. NPR's Scott Simon speaks with Kaiser Health News reporter Bram Sable-Smith about what that means for patients.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Medical Xpress
MARCH 18, 2023
Recently incarcerated people with opioid use disorder have trust in working with peer support specialists who recovered from addiction and faced similar life experiences, according to a Rutgers study.
NPR Health - Shots
MARCH 18, 2023
State abortion laws are changing the way some medical residents in the fields of obstetrics and gynecology will be trained.
Drug Patent Watch
MARCH 18, 2023
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs. This is one of the longest exclusivity terms provided by… The post Pharmaceutical companies with the most ‘New Chemical Entity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
246 
Let's personalize your content